Retroperitoneal abscess: Difference between revisions
Ahmed Younes (talk | contribs) |
m (Bot: Removing from Primary care) |
||
(37 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}};{{AE}}{{AY}} | {{CMG}};{{AE}}{{AY}} | ||
{{SK}} RP abscess | |||
==Overview== | ==Overview== | ||
Retroperitoneal abscess is an unusual type of abscess in surgical practice. It is often underdiagnosed due to the insidious onset of symptoms and its location in the retroperitoneal space making it hard to be | Retroperitoneal abscess is an unusual type of abscess in surgical practice. It is often underdiagnosed due to the insidious onset of symptoms and its location in the retroperitoneal space making it hard to be assessed via the regular abdominal examination. | ||
It is most often due to [[Genitourinary]] infection ( | It is most often due to [[Genitourinary]] infection ([[Pyelonephritis]]) or [[gastrointestinal]] cause (i.e [[Inflammatory Bowel Syndrome]]). | ||
CT & MRI are the cornerstones for diagnosis. | [[CT]] & [[MRI]] are the cornerstones for [[diagnosis]]. | ||
Treatment is usually focused on surgical drainage either through open or percutaneous approaches usually accompanied with the use of IV [[antibiotics]] . | Treatment is usually focused on surgical drainage either through open or [[percutaneous]] approaches usually accompanied with the use of IV [[antibiotics]]. | ||
==Historical perspective== | ==Historical perspective== | ||
*Retroperitoneal abscess was first described by Grassi and Serge in 1887. | *Retroperitoneal abscess was first described by Grassi and Serge in 1887. | ||
*Dr. Hugh Cabbot presented the first case of | *Dr. Hugh Cabbot presented the first case of retroperitoneal abscess in a case report in 1922. | ||
==Classification== | ==Classification== | ||
Retroperitoneal abscess may be classified according to the location in the retroperitoneal space into 5 categories <ref name="pmid1492717">{{cite journal| author=Grollier G, Burucoa C, Bonnin M, de Rautlin de La Roy Y| title=Identification and susceptibility testing for obligate anaerobic bacteria using a semi-automated API ATB plus system. | journal=Ann Biol Clin (Paris) | year= 1992 | volume= 50 | issue= 6-7 | pages= 393-7 | pmid=1492717 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1492717 }} </ref> : | Retroperitoneal abscess may be classified according to the location in the retroperitoneal space into 5 categories <ref name="pmid1492717">{{cite journal| author=Grollier G, Burucoa C, Bonnin M, de Rautlin de La Roy Y| title=Identification and susceptibility testing for obligate anaerobic bacteria using a semi-automated API ATB plus system. | journal=Ann Biol Clin (Paris) | year= 1992 | volume= 50 | issue= 6-7 | pages= 393-7 | pmid=1492717 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1492717 }} </ref> : | ||
*[[Perinephric abscess|Perinephric]] | *[[Perinephric abscess|Perinephric]] abscess | ||
*Upper [[retroperitoneal]] | *Upper [[retroperitoneal]] abscess | ||
*[[Pelvic]] | *[[Pelvic]] abscess | ||
*Combined [[retroperitoneal]] and [[pelvic]] | *Combined [[retroperitoneal]] and [[pelvic]] abscess | ||
*Lٍٍocalized [[musculoskeletal]] | *Lٍٍocalized [[musculoskeletal]] abscess | ||
==Pathophysiology== | ==Pathophysiology== | ||
{| style="float: right; width: 350px;" | {| style="float: right; width: 350px;" | ||
| [[Image:Capture 2.png| | | [[Image:Capture 2.png|center|400px|thumb|Retroperitoneal space - Case courtesy of Dr Matt Skalski, <a href="https://radiopaedia.org/">Radiopaedia.org</a>. From the case <a href="https://radiopaedia.org/cases/44105">rID: 44105</a>, Labels have been added to the image]] | ||
|} | |} | ||
===Pathogenesis=== | ===Pathogenesis=== | ||
* A retroperitoneal abscess is usually secondary to spread from other primary site either through hematogenous or by contiguous spread. | |||
The [[bacteria]] causing the abscess depends on the primary site. | * The [[bacteria]] causing the abscess depends on the primary site. When the [[bacteria]] invades the [[retroperitoneal]] tissue, [[toxins]] released from it destroy the tissues and trigger an [[inflammatory response]]. | ||
When the [[bacteria]] invades the retroperitoneal tissue, [[toxins]] released from it destroy the | * As a result of the [[inflammatory response]], [[WBC|white blood cells]] get recruited. They phagocytose the invading [[bacteria]] but at the same time they break down the infected [[tissue]]. | ||
* The healthy tissues around enclose the area with a membrane surrounding the [[abscess]]. | |||
As a result of the [[inflammatory response]], [[WBC| | * After [[pus]] evacuation, the membrane grows in to fill the [[cavity]]. | ||
The healthy tissues around enclose the area with a membrane surrounding the [[abscess]]. | |||
After [[pus]] evacuation, the membrane grows in to fill the cavity. | ===Microscopic findings=== | ||
===Microscopic | * The [[Abscess]] consists of a mixture of [[inflammatory cells]] together with debris tissue. | ||
[[Abscess]] consists of a mixture of inflammatory cells together with debris tissue. From the surrounding wall grows some [[capillaries]] to form [[granulation tissue]]. | * From the surrounding wall grows some [[capillaries]] to form [[granulation tissue]]. | ||
If body defenses are successful in eliminating the [[infection]], the [[granulation tissue]] continues to grow and the [[abscess]] continues to shrink in size until it is only a [[scar]]. | * If the body defenses are successful in eliminating the [[infection]], the [[granulation tissue]] continues to grow and the [[abscess]] continues to shrink in size until it is only a [[scar]]. | ||
If the offending [[pathogen]] is not cleared, the process goes on and may | * If the offending [[pathogen]] is not cleared, the process goes on and may eventually spread. | ||
==Causes== | ==Causes== | ||
Retroperitoneal Abscess may be caused by :<ref name="pmid27220893">{{cite journal| author=Winter BM, Gajda M, Grimm MO| title=[Diagnosis and treatment of retroperitoneal abscesses]. | journal=Urologe A | year= 2016 | volume= 55 | issue= 6 | pages= 741-7 | pmid=27220893 | doi=10.1007/s00120-016-0118-1 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27220893 }} </ref> | |||
Retroperitoneal Abscess may be caused by<ref name="pmid27220893">{{cite journal| author=Winter BM, Gajda M, Grimm MO| title=[Diagnosis and treatment of retroperitoneal abscesses]. | journal=Urologe A | year= 2016 | volume= 55 | issue= 6 | pages= 741-7 | pmid=27220893 | doi=10.1007/s00120-016-0118-1 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27220893 }} </ref> | *[[E. Coli]] or [[Proteus]] spp (if the primary site is the [[urinary tract]]) | ||
*[[E. Coli]] or [[Proteus]] spp (if primary is | |||
*Multibacterial & [[anaerobes]] (if gastrointestinal tract (GIT) is the primary source) | *Multibacterial & [[anaerobes]] (if gastrointestinal tract (GIT) is the primary source) | ||
*[[Staphylococcus aureus]] (if from distant septic focus) | *[[Staphylococcus aureus]] (if from distant [[Septic|septic focus]]) | ||
*[[Tuberculosis]] (if secondary to [[Pott's disease|Pott’s disease]]) | *[[Tuberculosis]] (if secondary to [[Pott's disease|Pott’s disease]]) | ||
==Differentiating | ==Differentiating retroperitoneal abscess from other Diseases== | ||
{| class="wikitable" | {| class="wikitable" | ||
! rowspan="2" |Disease | ! rowspan="2" |Disease | ||
Line 65: | Line 63: | ||
| | | | ||
|✔ | |✔ | ||
|[[Leukocytosis]] | |[[Leukocytosis]] and positive inflammatory markers | ||
| rowspan="4" |[[MRI]] is the best radiologic tool to differentiate between retroperitoneal masses. | | rowspan="4" |[[MRI]] is the best radiologic tool to differentiate between retroperitoneal masses. | ||
|- | |- | ||
Line 78: | Line 76: | ||
|✔ | |✔ | ||
|✔ | |✔ | ||
| | |Positive [[tumor marker]] | ||
|- | |- | ||
|[[Chronic pancreatitis]] | |[[Chronic pancreatitis]] | ||
Line 84: | Line 82: | ||
|✔ | |✔ | ||
|✔ | |✔ | ||
|[[ | |Elevated blood sugar (due to [[diabetes mellitus]]), [[amylase]] and [[lipase]] levels may be slightly elevated | ||
|} | |} | ||
==Epidemiology and | ==Epidemiology and demographics== | ||
Retroperitoneal abscess is far less common than | Retroperitoneal abscess is far less common than intraperitoneal abscesses.<ref name="pmid8028724">{{cite journal| author=Vitale L, Kiss A, Drago GW| title=[Retroperitoneal abscesses: clinical and therapeutical aspects]. | journal=Minerva Chir | year= 1994 | volume= 49 | issue= 3 | pages= 163-5 | pmid=8028724 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8028724 }} </ref> | ||
*[[Males]] are slightly more susceptible than [[females]]. | *[[Males]] are slightly more susceptible than [[females]]. | ||
*Increased incidence between third and sixth decades. | *Increased incidence between third and sixth decades. | ||
*Most common cause in developing countries is spread from distant septic focus. | *Most common cause in developing countries is spread from distant septic focus. | ||
*Most common | *Most common causes in developed countries are [[Renal]] and [[GI]] causes. <ref name="pmid27220893">{{cite journal| author=Winter BM, Gajda M, Grimm MO| title=[Diagnosis and treatment of retroperitoneal abscesses]. | journal=Urologe A | year= 2016 | volume= 55 | issue= 6 | pages= 741-7 | pmid=27220893 | doi=10.1007/s00120-016-0118-1 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27220893 }} </ref> | ||
==Risk Factors== | ==Risk Factors== | ||
Any septic focus can | Any septic focus can theoretically lead to retroperitoneal abscess. These are the primary foci in order of frequency of causing retroperitoneal abscess. | ||
*[[Renal]] infections : | *[[Renal]] infections: | ||
*[[Gastrointestinal tract|Gastrointestinal]] diseases : Spread from the [[gastrointestinal tract]] is the second common cause | :Spread from the urinary tract is the most common cause. | ||
*[[Bone]] infection : [[pott's disease]] or [[osteomyelitis]] | *[[Gastrointestinal tract|Gastrointestinal]] diseases: | ||
*Hematogenous spread : | :Spread from the [[gastrointestinal tract]] is the second common cause (e.g. perforated [[appendix]], <nowiki/>perforated [[colon cancer]], [[diverticulitis]] ,and [[Crohn’s disease|cohn’s disease]].) | ||
*[[Iatrogenic]] : | *[[Bone]] infection: | ||
:e.g. [[pott's disease]] or [[osteomyelitis]] | |||
*Hematogenous spread: | |||
:From distant septic foci. | |||
*[[Iatrogenic]]: | |||
:Following [[abdominal]] or [[pelvic]] surgery. | |||
Any condition compromising the [[immune system]] is a risk factor for developing retroperitoneal abscess. The following were the risk factors | Any condition compromising the [[immune system]] is a [[risk factor]] for developing retroperitoneal abscess. The following were the [[Risk factor|risk factors]] in observed patients. <ref name="pmid1492717">{{cite journal| author=Grollier G, Burucoa C, Bonnin M, de Rautlin de La Roy Y| title=Identification and susceptibility testing for obligate anaerobic bacteria using a semi-automated API ATB plus system. | journal=Ann Biol Clin (Paris) | year= 1992 | volume= 50 | issue= 6-7 | pages= 393-7 | pmid=1492717 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1492717 }} </ref> | ||
*[[Diabetes Mellitus]] | *[[Diabetes Mellitus]] | ||
*[[Cirrhosis]] | *[[Cirrhosis]] | ||
Line 116: | Line 119: | ||
==Natural History, Complications and Prognosis:== | ==Natural History, Complications and Prognosis:== | ||
===Natural | ===Natural history=== | ||
If left untreated, | If left untreated, retroperitoneal abscess may cause [[septicemia]] with very high incidence of [[morbidity]] and [[mortality]]. | ||
===Complications :=== | ===Complications :=== | ||
Most complications result from [[septicemia]] which presents late in the disease<ref name="pmid1492717">{{cite journal| author=Grollier G, Burucoa C, Bonnin M, de Rautlin de La Roy Y| title=Identification and susceptibility testing for obligate anaerobic bacteria using a semi-automated API ATB plus system. | journal=Ann Biol Clin (Paris) | year= 1992 | volume= 50 | issue= 6-7 | pages= 393-7 | pmid=1492717 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1492717 }} </ref> | Most complications result from [[septicemia]] which presents late in the disease.<ref name="pmid1492717">{{cite journal| author=Grollier G, Burucoa C, Bonnin M, de Rautlin de La Roy Y| title=Identification and susceptibility testing for obligate anaerobic bacteria using a semi-automated API ATB plus system. | journal=Ann Biol Clin (Paris) | year= 1992 | volume= 50 | issue= 6-7 | pages= 393-7 | pmid=1492717 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1492717 }} </ref> | ||
*[[Pneumonia]] and [[respiratory failure]] type 1 is the most common complication with very high mortality. | *[[Pneumonia]] and [[respiratory failure]] type 1 is the most common complication with very high [[mortality]]. | ||
*Recurrent [[Abscess]] after drainage. | *Recurrent [[Abscess]] after drainage. | ||
*[[Renal Failure]] | *[[Renal Failure]] | ||
Line 129: | Line 132: | ||
*Arterial [[Thrombosis]] | *Arterial [[Thrombosis]] | ||
*[[UTI]] | *[[UTI]] | ||
*[[Brain Abscess]] | *[[Brain Abscess|Brain abscess]] | ||
*[[Empyema]] | *[[Empyema]] | ||
*[[Osteomyelitis]] | *[[Osteomyelitis]] | ||
===Prognosis === | ===Prognosis === | ||
Depending on the extent of the abscess at the time of diagnosis, the prognosis may vary. However, with the presence of the mentioned factors below, the prognosis is generally regarded | Depending on the extent of the [[abscess]] at the time of [[diagnosis]], the [[prognosis]] may vary. However, with the presence of the mentioned factors below, the prognosis is generally regarded poor.<ref name="pmid1492717">{{cite journal| author=Grollier G, Burucoa C, Bonnin M, de Rautlin de La Roy Y| title=Identification and susceptibility testing for obligate anaerobic bacteria using a semi-automated API ATB plus system. | journal=Ann Biol Clin (Paris) | year= 1992 | volume= 50 | issue= 6-7 | pages= 393-7 | pmid=1492717 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1492717 }} </ref> | ||
*[[Septicemia]] (Positive Blood Culture) : Not | *[[Septicemia]] (Positive Blood [[Culture medium|Culture]]) : Not presenting in every patient but when present, it is a very poor prognostic sign. | ||
*Number of days for [[fever]] to fade away after drainage : Persistence of fever more than 4 days carries a mortality more than 70%. | *Number of days for [[fever]] to fade away after drainage: Persistence of [[fever]] more than 4 days carries a [[mortality]] more than 70%. | ||
==Diagnosis== | ==Diagnosis== | ||
===History=== | ===History=== | ||
* A detailed history should be obtained from the patient presenting with insidious onset of abdominal pain. | |||
* Common causes should be investigated ([[Kidney]] and [[Gastrointestinal tract|gastrointestinal]] diseases) especially in the presence of any of the risk factors (e.g. [[DM]] and [[corticosteroid]] administration). | |||
===Symptoms <ref name="pmid1492717">{{cite journal| author=Grollier G, Burucoa C, Bonnin M, de Rautlin de La Roy Y| title=Identification and susceptibility testing for obligate anaerobic bacteria using a semi-automated API ATB plus system. | journal=Ann Biol Clin (Paris) | year= 1992 | volume= 50 | issue= 6-7 | pages= 393-7 | pmid=1492717 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1492717 }} </ref>:=== | ===Symptoms <ref name="pmid1492717">{{cite journal| author=Grollier G, Burucoa C, Bonnin M, de Rautlin de La Roy Y| title=Identification and susceptibility testing for obligate anaerobic bacteria using a semi-automated API ATB plus system. | journal=Ann Biol Clin (Paris) | year= 1992 | volume= 50 | issue= 6-7 | pages= 393-7 | pmid=1492717 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1492717 }} </ref>:=== | ||
Given that the presentation is usually insidious, nonspecific | Given that the presentation is usually insidious, nonspecific beside that it’s an unusual condition .. the diagnosis is usually delayed. | ||
====Common symptoms:==== | ====Common symptoms:==== | ||
*[[Fever]] is the most common complaint usually | *[[Fever]] is the most common complaint and usually it is more than 101 F. | ||
*Constitutional symptoms : [[ | *Constitutional symptoms : [[chills]], [[malaise]], [[anorexia]] and [[weight loss]]. | ||
*[[Abdominal pain]] : | *[[Abdominal pain]] : Not localized due to the unusual site of the [[abscess]]. | ||
====Less common symptoms:==== | ====Less common symptoms:==== | ||
*[[Gastrointestinal tract|Gastrointestinal]] complaints which | *[[Gastrointestinal tract|Gastrointestinal]] complaints which varies from case to case | ||
*If abscess involves [[psoas major muscle]], pain is usually referred to the [[Hip (anatomy)|hip]], [[groin]] and [[knee]]. | *If abscess involves [[psoas major muscle]], pain is usually referred to the [[Hip (anatomy)|hip]], [[groin]] and [[knee]]. | ||
Line 161: | Line 165: | ||
*[[Tachycardia]] | *[[Tachycardia]] | ||
*[[Tachypnea]] | *[[Tachypnea]] | ||
*[[Hypotension]] (if | *[[Hypotension]] (if patient is presenting with [[shock]]) | ||
===Abdominal Examination=== | ===Abdominal Examination=== | ||
*[[Abdominal tenderness]] is often present (localized) | *[[Abdominal tenderness]] is often present (localized). | ||
*Positive [[psoas sign]] if the [[psoas muscle]] is involved. | *Positive [[psoas sign]] if the [[psoas muscle]] is involved. | ||
*The classic signs of [[peritonitis]] is absent (making the diagnosis more difficult). | *The classic signs of [[peritonitis]] is absent (making the diagnosis more difficult). | ||
===Lab Findings=== | ===Lab Findings=== | ||
*Classic lab findings of [[inflammation]] as [[leukocytosis]], high [[Erythrocyte sedimentation rate|ESR]], high [[C-reactive protein|CRP]] ,etc, ...Leukocytosis is usually not | *Classic lab findings of [[inflammation]] as [[leukocytosis]], high [[Erythrocyte sedimentation rate|ESR]], high [[C-reactive protein|CRP]] ,etc, ...[[Leukocytosis]] is usually not extremely high (between 10,000 and 20,000 in most cases) | ||
*[[Blood culture]] is not always positive (but carries a grave prognosis if positive).Organism depends on the source of [[abscess]] as mentioned above in pathophysiology. | *[[Blood culture]] is not always positive (but carries a grave prognosis if positive).Organism depends on the source of [[abscess]] as mentioned above in pathophysiology. | ||
===Radiological Findings=== | ===Radiological Findings=== | ||
CT & MRI are the 2 most important radiological diagnostic tools. | [[CT]] & [[MRI]] are the 2 most important radiological diagnostic tools. | ||
[[Image: | [[Image:rp_abscess_gif.gif|500px|thumb|center|Case courtesy of Dr MohammadTaghi Niknejad, <a href="https://radiopaedia.org/">Radiopaedia.org</a>. From the case <a href="https://radiopaedia.org/cases/20859">rID: 20859</a>]] | ||
*The image shows retroperitoneal abscess in left side with gas bubbles inside (circled area) | *The image shows retroperitoneal abscess in left side with gas bubbles inside (circled area) | ||
==== | ====CT==== | ||
*[[Computed tomography|CT]] shows fluid collection in the retroperitoneal space and may also show gas bubbles. It is also helpful in determining the primary source of the [[abscess]]. | *[[Computed tomography|CT]] shows fluid collection in the [[Retroperitoneum|retroperitoneal]] space and may also show gas bubbles. It is also helpful in determining the primary source of the [[abscess]]. | ||
==== | ====MRI==== | ||
*Shows the same findings as [[Computed tomography|CT]], but more sensitive. | *Shows the same findings as [[Computed tomography|CT]], but more sensitive. | ||
==== | ====Ultrasonography==== | ||
*Not the preferred diagnostic tool because of the remote site of the abscess. | *Not the preferred diagnostic tool because of the remote site of the [[abscess]]. | ||
==Treatment== | ==Treatment== | ||
===Overview=== | ===Overview=== | ||
Surgery is the mainstay of treatment together with the proper use of [[antibiotics]]. | [[Surgery]] is the mainstay of treatment together with the proper use of [[Antibiotic|antibiotics]]. | ||
===Medical Treatment=== | ===Medical Treatment=== | ||
*Intravenous empiric [[antibiotics]] should be started till results of the cultures are available.<ref name="pmid1492717">{{cite journal| author=Grollier G, Burucoa C, Bonnin M, de Rautlin de La Roy Y| title=Identification and susceptibility testing for obligate anaerobic bacteria using a semi-automated API ATB plus system. | journal=Ann Biol Clin (Paris) | year= 1992 | volume= 50 | issue= 6-7 | pages= 393-7 | pmid=1492717 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1492717 }} </ref> | *Intravenous empiric [[antibiotics]] should be started till results of the [[Bacterial cultures|cultures]] are available.<ref name="pmid1492717">{{cite journal| author=Grollier G, Burucoa C, Bonnin M, de Rautlin de La Roy Y| title=Identification and susceptibility testing for obligate anaerobic bacteria using a semi-automated API ATB plus system. | journal=Ann Biol Clin (Paris) | year= 1992 | volume= 50 | issue= 6-7 | pages= 393-7 | pmid=1492717 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1492717 }} </ref> | ||
{| class="wikitable" | {| class="wikitable" | ||
|+Initial Empiric antibiotic therapy for community acquired intraabdominal infections<ref name="urlwww.idsociety.org">{{cite web |url=https://www.idsociety.org/uploadedFiles/IDSA/Guidelines-Patient_Care/PDF_Library/Intra-abdominal%20Infectin.pdf |title=www.idsociety.org |format= |work= |accessdate=}}</ref> | |+Initial Empiric antibiotic therapy for community acquired intraabdominal infections<ref name="urlwww.idsociety.org">{{cite web |url=https://www.idsociety.org/uploadedFiles/IDSA/Guidelines-Patient_Care/PDF_Library/Intra-abdominal%20Infectin.pdf |title=www.idsociety.org |format= |work= |accessdate=}}</ref> | ||
! rowspan="2 | ! rowspan="2" style="background:#D3D3D3;" align="center" |Regimen | ||
! rowspan="2 | ! rowspan="2" style="background:#D3D3D3;" align="center" |Pediatrics | ||
! colspan="2 | ! colspan="2" style="background:#D3D3D3;" align="center" |Adults | ||
|- | |- | ||
| | | style="background:#DCDCDC;" align="center" |Mild - Moderate infection | ||
| | | style="background:#DCDCDC;" align="center" |Severe infection | ||
|- | |- | ||
|Single agent | |Single agent | ||
|[[Ertapenem]], [[meropenem]], [[imipenem]], [[cilastatin]], [[Ticarcillin-Clavulanate|ticarcillin-clavulanate]], and [[piperacillin-tazobactam]] | |[[Ertapenem]], [[meropenem]], [[imipenem]], [[cilastatin]], [[Ticarcillin-Clavulanate|ticarcillin-clavulanate]], and [[piperacillin-tazobactam]] | ||
|[[Cefoxitin]], [[ertapenem]], [[moxifloxacin]], [[tigecycline]], and [[ticarcillin-clavulanic]] | |[[Cefoxitin]], [[ertapenem]], [[moxifloxacin]], [[tigecycline]], and [[Ticarcillin-Clavulanate|ticarcillin-clavulanic acid]] | ||
|[[Imipenem-cilastatin]], [[meropenem]], [[doripenem]], and [[piperacillin-tazobactam]] | |[[Imipenem-Cilastatin|Imipenem-cilastatin]], [[meropenem]], [[doripenem]], and [[piperacillin-tazobactam]] | ||
|- | |- | ||
|Combination | |Combination | ||
Line 209: | Line 213: | ||
{| class="wikitable" | {| class="wikitable" | ||
|+<sup>Initial Empiric antibiotic therapy for health care associated intraabdominal infections.</sup><ref name="urlwww.idsociety.org">{{cite web |url=https://www.idsociety.org/uploadedFiles/IDSA/Guidelines-Patient_Care/PDF_Library/Intra-abdominal%20Infectin.pdf |title=www.idsociety.org |format= |work= |accessdate=}}</ref> | |+<sup>Initial Empiric antibiotic therapy for health care associated intraabdominal infections.</sup><ref name="urlwww.idsociety.org">{{cite web |url=https://www.idsociety.org/uploadedFiles/IDSA/Guidelines-Patient_Care/PDF_Library/Intra-abdominal%20Infectin.pdf |title=www.idsociety.org |format= |work= |accessdate=}}</ref> | ||
! rowspan="2" style="background:#D3D3D3;"|Organisms that are common in health care facility | ! rowspan="2" style="background:#D3D3D3;" |Organisms that are common in health care facility | ||
! colspan="5" style="background:#D3D3D3;"|Regimen | ! colspan="5" style="background:#D3D3D3;" |Regimen | ||
|- | |- | ||
!style="background:#DCDCDC;"|[[Carbapenem]] | ! style="background:#DCDCDC;" |[[Carbapenem]] | ||
!style="background:#DCDCDC;"|[[Aminoglycoside]] | ! style="background:#DCDCDC;" |[[Aminoglycoside]] | ||
!style="background:#DCDCDC;"|[[Ceftazidime]] or [[cefepime]], each with [[metronidazole]] | ! style="background:#DCDCDC;" |[[Ceftazidime]] or [[cefepime]], each with [[metronidazole]] | ||
!style="background:#DCDCDC;"|[[Piperacillin-tazobactam]] | ! style="background:#DCDCDC;" |[[Piperacillin-tazobactam]] | ||
!style="background:#DCDCDC;"|[[Vancomycin]] | ! style="background:#DCDCDC;" |[[Vancomycin]] | ||
|- | |- | ||
|<20% Resistant [[Pseudomonas aeruginosa]], extended-spectrum | |<20% Resistant [[Pseudomonas aeruginosa]], extended-spectrum b-lactamase-producing [[Enterobacteriaceae]], [[Acinetobacter]], or other multidrug resistant [[gram-negative bacilli]] | ||
|Recommended | |Recommended | ||
|Not recommended | |Not recommended | ||
Line 225: | Line 229: | ||
|Not recommended† | |Not recommended† | ||
|- | |- | ||
|Extended-spectrum b-lactamase-producing [[Enterobacteriaceae]] | |||
|Recommended | |Recommended | ||
|Recommended | |Recommended | ||
Line 247: | Line 251: | ||
|} | |} | ||
*Drainage of the [[abscess]] is a must and using medical treatment alone carries a [[mortality rate]] approaching 100 % in some studies. | *Drainage of the [[abscess]] is a must and using [[medical treatment]] alone carries a [[mortality rate]] approaching 100 % in some studies. | ||
===Surgical Treatment :=== | ===Surgical Treatment :=== | ||
*Operative treatment is usually preferred unless | *Operative treatment is usually preferred unless there is a special condition for which surgery is contraindicated.<ref name="pmid1492717">{{cite journal| author=Grollier G, Burucoa C, Bonnin M, de Rautlin de La Roy Y| title=Identification and susceptibility testing for obligate anaerobic bacteria using a semi-automated API ATB plus system. | journal=Ann Biol Clin (Paris) | year= 1992 | volume= 50 | issue= 6-7 | pages= 393-7 | pmid=1492717 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1492717 }} </ref> | ||
*Retroperitoneal or pelvic approaches are much preferred than transperitoneal approach due to better outcomes and decreased probability of intraperitoneal spread. | *[[Retroperitoneal]] or [[pelvic]] approaches are much more preferred than transperitoneal approach due to better outcomes and decreased probability of [[intraperitoneal]] spread. | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Emergency medicine]] | |||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Hepatology]] | |||
[[Category:Pulmonology]] | |||
[[Category:Surgery]] |
Latest revision as of 23:59, 29 July 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Ahmed Younes M.B.B.CH [2]
Synonyms and keywords: RP abscess
Overview
Retroperitoneal abscess is an unusual type of abscess in surgical practice. It is often underdiagnosed due to the insidious onset of symptoms and its location in the retroperitoneal space making it hard to be assessed via the regular abdominal examination. It is most often due to Genitourinary infection (Pyelonephritis) or gastrointestinal cause (i.e Inflammatory Bowel Syndrome). CT & MRI are the cornerstones for diagnosis. Treatment is usually focused on surgical drainage either through open or percutaneous approaches usually accompanied with the use of IV antibiotics.
Historical perspective
- Retroperitoneal abscess was first described by Grassi and Serge in 1887.
- Dr. Hugh Cabbot presented the first case of retroperitoneal abscess in a case report in 1922.
Classification
Retroperitoneal abscess may be classified according to the location in the retroperitoneal space into 5 categories [1] :
- Perinephric abscess
- Upper retroperitoneal abscess
- Pelvic abscess
- Combined retroperitoneal and pelvic abscess
- Lٍٍocalized musculoskeletal abscess
Pathophysiology
Pathogenesis
- A retroperitoneal abscess is usually secondary to spread from other primary site either through hematogenous or by contiguous spread.
- The bacteria causing the abscess depends on the primary site. When the bacteria invades the retroperitoneal tissue, toxins released from it destroy the tissues and trigger an inflammatory response.
- As a result of the inflammatory response, white blood cells get recruited. They phagocytose the invading bacteria but at the same time they break down the infected tissue.
- The healthy tissues around enclose the area with a membrane surrounding the abscess.
- After pus evacuation, the membrane grows in to fill the cavity.
Microscopic findings
- The Abscess consists of a mixture of inflammatory cells together with debris tissue.
- From the surrounding wall grows some capillaries to form granulation tissue.
- If the body defenses are successful in eliminating the infection, the granulation tissue continues to grow and the abscess continues to shrink in size until it is only a scar.
- If the offending pathogen is not cleared, the process goes on and may eventually spread.
Causes
Retroperitoneal Abscess may be caused by :[2]
- E. Coli or Proteus spp (if the primary site is the urinary tract)
- Multibacterial & anaerobes (if gastrointestinal tract (GIT) is the primary source)
- Staphylococcus aureus (if from distant septic focus)
- Tuberculosis (if secondary to Pott’s disease)
Differentiating retroperitoneal abscess from other Diseases
Disease | Clinical feature | Laboratory findings | Imaging findings | ||
---|---|---|---|---|---|
Fever | Weight loss | Abdominal pain | |||
Retroperitoneal abscess | ✔ | ✔ | Leukocytosis and positive inflammatory markers | MRI is the best radiologic tool to differentiate between retroperitoneal masses. | |
Retroperitoneal hematoma | ✔ | Anemia | |||
Retroperitoneal tumors (.e.g. liposarcoma) | ✔ | ✔ | ✔ | Positive tumor marker | |
Chronic pancreatitis | ✔ | ✔ | Elevated blood sugar (due to diabetes mellitus), amylase and lipase levels may be slightly elevated |
Epidemiology and demographics
Retroperitoneal abscess is far less common than intraperitoneal abscesses.[3]
- Males are slightly more susceptible than females.
- Increased incidence between third and sixth decades.
- Most common cause in developing countries is spread from distant septic focus.
- Most common causes in developed countries are Renal and GI causes. [2]
Risk Factors
Any septic focus can theoretically lead to retroperitoneal abscess. These are the primary foci in order of frequency of causing retroperitoneal abscess.
- Renal infections:
- Spread from the urinary tract is the most common cause.
- Gastrointestinal diseases:
- Spread from the gastrointestinal tract is the second common cause (e.g. perforated appendix, perforated colon cancer, diverticulitis ,and cohn’s disease.)
- Bone infection:
- e.g. pott's disease or osteomyelitis
- Hematogenous spread:
- From distant septic foci.
Any condition compromising the immune system is a risk factor for developing retroperitoneal abscess. The following were the risk factors in observed patients. [1]
- Diabetes Mellitus
- Cirrhosis
- Malignancy
- Remote infection
- Glucocorticoids administration
- Chronic renal failure
Screening
According to the USPSTF, screening for retroperitoneal abscess is not recommended.
Natural History, Complications and Prognosis:
Natural history
If left untreated, retroperitoneal abscess may cause septicemia with very high incidence of morbidity and mortality.
Complications :
Most complications result from septicemia which presents late in the disease.[1]
- Pneumonia and respiratory failure type 1 is the most common complication with very high mortality.
- Recurrent Abscess after drainage.
- Renal Failure
- DVT
- Small Bowel Obstruction
- Arterial Thrombosis
- UTI
- Brain abscess
- Empyema
- Osteomyelitis
Prognosis
Depending on the extent of the abscess at the time of diagnosis, the prognosis may vary. However, with the presence of the mentioned factors below, the prognosis is generally regarded poor.[1]
- Septicemia (Positive Blood Culture) : Not presenting in every patient but when present, it is a very poor prognostic sign.
- Number of days for fever to fade away after drainage: Persistence of fever more than 4 days carries a mortality more than 70%.
Diagnosis
History
- A detailed history should be obtained from the patient presenting with insidious onset of abdominal pain.
- Common causes should be investigated (Kidney and gastrointestinal diseases) especially in the presence of any of the risk factors (e.g. DM and corticosteroid administration).
Symptoms [1]:
Given that the presentation is usually insidious, nonspecific beside that it’s an unusual condition .. the diagnosis is usually delayed.
Common symptoms:
- Fever is the most common complaint and usually it is more than 101 F.
- Constitutional symptoms : chills, malaise, anorexia and weight loss.
- Abdominal pain : Not localized due to the unusual site of the abscess.
Less common symptoms:
- Gastrointestinal complaints which varies from case to case
- If abscess involves psoas major muscle, pain is usually referred to the hip, groin and knee.
Physical Exam
General Appearance
The patient is usually fatigued & looking ill due to the preexisting risk factor. In advanced cases with septicemia, the patient may be drowsy with decreased level of consciousness.[1]
Vital signs
- Fever
- Tachycardia
- Tachypnea
- Hypotension (if patient is presenting with shock)
Abdominal Examination
- Abdominal tenderness is often present (localized).
- Positive psoas sign if the psoas muscle is involved.
- The classic signs of peritonitis is absent (making the diagnosis more difficult).
Lab Findings
- Classic lab findings of inflammation as leukocytosis, high ESR, high CRP ,etc, ...Leukocytosis is usually not extremely high (between 10,000 and 20,000 in most cases)
- Blood culture is not always positive (but carries a grave prognosis if positive).Organism depends on the source of abscess as mentioned above in pathophysiology.
Radiological Findings
CT & MRI are the 2 most important radiological diagnostic tools.
- The image shows retroperitoneal abscess in left side with gas bubbles inside (circled area)
CT
- CT shows fluid collection in the retroperitoneal space and may also show gas bubbles. It is also helpful in determining the primary source of the abscess.
MRI
- Shows the same findings as CT, but more sensitive.
Ultrasonography
- Not the preferred diagnostic tool because of the remote site of the abscess.
Treatment
Overview
Surgery is the mainstay of treatment together with the proper use of antibiotics.
Medical Treatment
- Intravenous empiric antibiotics should be started till results of the cultures are available.[1]
Regimen | Pediatrics | Adults | |
---|---|---|---|
Mild - Moderate infection | Severe infection | ||
Single agent | Ertapenem, meropenem, imipenem, cilastatin, ticarcillin-clavulanate, and piperacillin-tazobactam | Cefoxitin, ertapenem, moxifloxacin, tigecycline, and ticarcillin-clavulanic acid | Imipenem-cilastatin, meropenem, doripenem, and piperacillin-tazobactam |
Combination | Ceftriaxone, cefotaxime, cefepime, or ceftazidime, each in combination with metronidazole; gentamicin or tobramycin, each in combination with metronidazole or clindamycin, and with or without ampicillin | Cefepime, ceftazidime, ciprofloxacin, or levofloxacin, each in combination with metronidazole. | Cefepime, ceftazidime, ciprofloxacin, or levofloxacin, each in combination with metronidazole. |
Organisms that are common in health care facility | Regimen | ||||
---|---|---|---|---|---|
Carbapenem | Aminoglycoside | Ceftazidime or cefepime, each with metronidazole | Piperacillin-tazobactam | Vancomycin | |
<20% Resistant Pseudomonas aeruginosa, extended-spectrum b-lactamase-producing Enterobacteriaceae, Acinetobacter, or other multidrug resistant gram-negative bacilli | Recommended | Not recommended | Recommended | Recommended | Not recommended† |
Extended-spectrum b-lactamase-producing Enterobacteriaceae | Recommended | Recommended | Not recommended | Recommended | Not recommended |
P. aeruginosa 120% resistant to ceftazidime | Recommended | Recommended | Not recommended | Recommended | Not recommended |
Methicillin-resistant Staphylococcus aureus | Not recommended | Not recommended | Not recommended | Not recommended | Recommended |
- Drainage of the abscess is a must and using medical treatment alone carries a mortality rate approaching 100 % in some studies.
Surgical Treatment :
- Operative treatment is usually preferred unless there is a special condition for which surgery is contraindicated.[1]
- Retroperitoneal or pelvic approaches are much more preferred than transperitoneal approach due to better outcomes and decreased probability of intraperitoneal spread.
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 Grollier G, Burucoa C, Bonnin M, de Rautlin de La Roy Y (1992). "Identification and susceptibility testing for obligate anaerobic bacteria using a semi-automated API ATB plus system". Ann Biol Clin (Paris). 50 (6–7): 393–7. PMID 1492717.
- ↑ 2.0 2.1 Winter BM, Gajda M, Grimm MO (2016). "[Diagnosis and treatment of retroperitoneal abscesses]". Urologe A. 55 (6): 741–7. doi:10.1007/s00120-016-0118-1. PMID 27220893.
- ↑ Vitale L, Kiss A, Drago GW (1994). "[Retroperitoneal abscesses: clinical and therapeutical aspects]". Minerva Chir. 49 (3): 163–5. PMID 8028724.
- ↑ 4.0 4.1 "www.idsociety.org" (PDF).